Conjugates for treating diseases caused by PSMA expressing cells
US-9636413-B2 · May 2, 2017 · US
US9402861B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9402861-B2 |
| Application number | US-201213603125-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 4, 2012 |
| Priority date | Mar 2, 2010 |
| Publication date | Aug 2, 2016 |
| Grant date | Aug 2, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Compositions and methods for making a composition comprising a polymer and one or more chelators covalently coupled to polymer, wherein the one or more chelators has a benzene ring with more than one hydroxyl group at any position that is free, or a derivative of the chelator, or a salt of the chelator and methods of use.
Opening claim text (preview).
What is claimed is: 1. A composition comprising: a polymeric chelator comprising a plurality of polyamine polymer backbone chains and one or more chelators, wherein the polyamine polymer backbone chains are polyallylamine or polylysine; wherein the one or more chelators are covalently coupled to one or more primary amines, respectively, of at least one of the plurality of polyamine polymer backbone chains through one or more amide bonds, respectively, wherein each of the one or more chelators has a benzene ring with more than one hydroxyl group at any position that is free; and wherein the plurality of polyamine polymer backbone chains are cross-linked to one another independent of any cross-linking that may result from interactions with the one or more chelators. 2. The composition of claim 1 , wherein the polymeric chelator is injectable. 3. The composition of claim 1 , wherein the polymeric chelator is a hydrogel. 4. The composition of claim 1 , wherein the polymeric chelator is ingestible. 5. The composition of claim 1 , wherein the one or more chelators are capable of chelating a metal. 6. The composition of claim 1 , wherein the one or more chelators are capable of chelating a heavy metal. 7. The composition of claim 1 , wherein the one or more chelators are capable of chelating aluminum, arsenic, cadmium, chromium, copper, iron, lead, manganese, mercury, or combination thereof. 8. The composition of claim 1 , wherein the one or more chelators are a derivative of a metal chelator. 9. The composition of claim 1 wherein each of the one or more chelators is derived from 2,3 dihydroxybenzoic acid. 10. The composition of claim 1 wherein the molar ratio of A to B is from about 0.07 to about 0.17, wherein A is chelators covalently coupled to primary amines, and wherein B is total amines of the polymeric chelator. 11. The composition of claim 1 wherein the molar ratio of A to B is from about 0.03 to about 0.22, wherein A is chelators covalently coupled to primary amines, and wherein B is total amines of the polymeric chelator.
Polyamides, e.g. nylon (polyamino acids A61K47/62) · CPC title
by a single or double bond to nitrogen · CPC title
Chelates, e.g. Gd-DOTA or Zinc-amino acid chelates; Chelate-forming compounds, e.g. DOTA or ethylenediamine being covalently linked or complexed to the pharmacologically- or therapeutically-active agent · CPC title
Compositions for preparing hydrogels · CPC title
obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.